Despite posting a record Q2 profit of €2.1 billion—a 30% surge driven by unusually low natural catastrophe costs (€20 million...

Insulet, a leading medical technology company, has impressed Wall Street with stellar quarterly results, prompting multiple analysts to raise price...

Berlin-based radiation and medical technology firm Eckert & Ziegler reported solid first-half 2025 results, with revenue rising 2% to €148.8...

Gilead Sciences surprised investors with stronger-than-expected Q2 results, driven by a surge in its HIV portfolio. The biotech giant reported...

Dutch cloud computing firm Nebius, a former Yandex spin-off, has stunned markets with explosive quarterly growth, reporting a 625% revenue...

Eli Lilly is poised to capitalize on explosive growth in India for its diabetes and weight-loss drug Mounjaro, with sales...

Merck's shares have hit their lowest level since mid-2020, trading at just €101.50—less than half their late-2021 peak of over...

The Munich-based industrial conglomerate reported solid yet uneven performance in Q3 2024/25, with revenue rising 3% to €19.4 billion (5%...

Sunrun's stock surged 13% after the solar provider reported blockbuster Q2 2025 results, defying analyst expectations with a record-breaking performance....

Carl Zeiss Meditec's shares plummeted by approximately 13% to €41.68 following its quarterly earnings report, despite posting a 7.6% revenue...